The active substance of the medicine is ibuprofen, which acts by reducing pain and fever.
The medicine is indicated for use in adults and adolescents over 12 years of age to relieve symptoms of mild or moderate pain, such as headache, toothache, menstrual pain, muscle pain (cramps), back pain (lower back pain), as well as in febrile conditions.
If after 3 days in the case of fever treatment or 3 days in the case of pain treatment in adolescents or after 5 days in the case of pain treatment in adults, the symptoms worsen or do not improve, the patient should consult a doctor.
LT/H/0162/001-002/II/006/G and II/007
leading to bloody diarrhea) or if the patient has a history of bleeding or perforation of the stomach or intestines.
Before starting treatment with Paduden Express Forte, the patient should discuss it with their doctor or pharmacist:
LT/H/0162/001-002/II/006/G and II/007
Taking anti-inflammatory/pain-relieving medications, such as ibuprofen, may be associated with a slight increase in the risk of heart attack or stroke, especially when taken in high doses. Do not exceed the recommended dose and duration of treatment.
Before starting treatment with Paduden Express Forte, the patient should discuss their treatment with their doctor or pharmacist if:
Medications of this type may cause fluid retention, especially in patients with heart failure and/or high blood pressure (hypertension).
During treatment with ibuprofen, symptoms of allergic reactions to this medicine have been observed, including difficulty breathing, swelling of the face and neck (angioedema), chest pain. If any of these symptoms are noticed, the patient should stop taking Paduden Express Forte and contact their doctor or emergency medical services immediately.
Severe skin reactions have been reported with ibuprofen, such as exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP). If the patient experiences any symptoms associated with these severe skin reactions described in section 4, they should stop taking Paduden Express Forte and seek medical attention immediately.
Paduden Express Forte may mask the symptoms of infection, such as fever and pain.
Therefore, Paduden Express Forte may delay the use of appropriate infection treatment and consequently lead to increased risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections associated with chickenpox. If the patient is taking this medicine during an infection and the symptoms of the infection persist or worsen, they should consult their doctor immediately.
The patient should tell their doctor or pharmacist about all medications they are currently taking or have recently taken, as well as any medications they plan to take.
Paduden Express Forte may affect the action of other medications or other medications may affect the action of Paduden Express Forte.
For example:
LT/H/0162/001-002/II/006/G and II/007
Also, some other medications may be affected or have an effect on treatment with Paduden Express Forte. Therefore, before taking Paduden Express Forte with other medications, the patient should always consult their doctor or pharmacist.
Interactions with analytical tests
In the case of performing any diagnostic tests (including blood tests, urine tests, skin tests with allergens, etc.), the patient should inform their doctor about taking this medicine, as it may change the results.
This medicine can be taken with or without food. It is recommended to take the medicine during meals to reduce the possibility of stomach disorders.
The patient should avoid taking ibuprofen with alcohol to avoid stomach damage.
Taking ibuprofen by patients who regularly consume alcohol (at least three servings of alcohol - beer, wine, spirits - per day) may cause stomach bleeding.
Taking this medicine with food may reduce the risk of stomach ulcers.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a baby, they should consult their doctor or pharmacist before taking this medicine.
In the first and second trimester of pregnancy, ibuprofen should not be taken unless it is clearly necessary, as taking the medicine may increase the risk of developmental abnormalities or miscarriage. In such cases, the patient should take the lowest dose for the shortest possible time.
Taking the medicine is contraindicated in the third trimester of pregnancy.
The patient should not take ibuprofen if they are in the last 3 months of pregnancy, as it may harm the unborn baby or cause complications during delivery.
It may cause kidney and heart problems in the unborn baby. It may increase the risk of bleeding in the patient and their baby and cause delayed or prolonged labor. During the first 6 months of pregnancy, the patient should not take the medicine unless it is absolutely necessary and recommended by a doctor. If treatment is necessary during this period or during attempts to become pregnant, the patient should take the smallest dose for the shortest possible time. After the 20th week of pregnancy, ibuprofen may cause kidney problems in the unborn baby if taken for more than a few days. This may lead to a decrease in the amount of amniotic fluid surrounding the baby (oligohydramnios) or narrowing of the arterial duct (ductus arteriosus) in the baby's heart. If treatment is necessary for a longer period, the doctor may recommend additional monitoring.
The medicine passes into breast milk, but it can be taken during breastfeeding if it is taken in the recommended doses and for the shortest possible period.
In women of childbearing age, it should be considered that taking medications containing ibuprofen may cause fertility disorders. The patient should avoid taking this medicine if they are trying to become pregnant.
Patients who experience dizziness, vision disturbances, or other symptoms while taking this medicine should avoid driving and operating machines.
The medicine contains 72.4 mg of sorbitol in each capsule, which corresponds to 1.03 mg/kg.
The medicine contains less than 1 mmol (39 mg) of potassium per capsule, which means the medicine is considered "potassium-free".
This medicine should always be taken exactly as described in this patient leaflet or as directed by the doctor or pharmacist. In case of doubt, the patient should consult their doctor or pharmacist.
The recommended dose is:
The patient should take the smallest effective dose for the shortest period necessary to relieve symptoms. If the symptoms of the infection (such as fever and pain) persist or worsen, the patient should consult their doctor immediately (see section 2).
The medicine should not be taken by children under 12 years of age due to the content of 400 mg of ibuprofen. Other strengths of the medicine are available for this age group.
Method of administration
The medicine is intended for oral use.
The capsules should be swallowed with a small amount of water. The capsules should not be chewed.
It is recommended that patients with sensitive stomachs take this medicine with food.
The medicine is indicated for use in case of pain or fever. If these symptoms disappear, the patient should stop taking the medicine.
If after 3 days in adolescents between 12 and 18 years of age the symptoms do not improve or worsen, the patient should consult their doctor.
If after 3 days in the case of fever treatment and 5 days in the case of pain treatment in adults the symptoms persist, the patient should consult their doctor.
If the patient has taken a larger dose of Paduden Express Forte than recommended or if children have accidentally taken the medicine, they should always contact their doctor or the nearest hospital for advice on the risk and actions to be taken.
Symptoms of overdose may include nausea, abdominal pain, vomiting (which may contain blood), gastrointestinal bleeding (see also section 4 below), diarrhea, headache, ringing in the ears, confusion, and nystagmus. It may also cause agitation, drowsiness, disorientation, or coma. Seizures have been observed in some patients. After taking a large dose of the medicine, drowsiness, chest pain, palpitations, loss of consciousness, seizures (mainly in children), weakness, and dizziness, blood in the urine, low potassium levels in the blood, feeling cold, and breathing difficulties have been observed. Additionally, the prothrombin time/INR may be prolonged, probably due to the effect on the action of circulating blood clotting factors. Acute kidney failure and liver damage may occur. In patients with asthma, worsening of asthma symptoms is possible. Apart from that, low blood pressure and slow breathing may occur.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The likelihood of side effects increases in patients over 65 years of age. The occurrence of side effects is less common in the case of short treatment duration and when the daily dose is less than the maximum recommended dose.
experience:
LT/H/0162/001-002/II/006/G and II/007
Widespread rash, high body temperature, and swollen lymph nodes (DRESS syndrome).
Frequent(may occur in less than 1 in 10 people):
Uncommon(may occur in less than 1 in 100 people):
Rare(may occur in less than 1 in 1,000 people):
Very rare(may occur in less than 1 in 10,000 people):
Frequency not known(frequency cannot be estimated from the available data):
Taking such medications as Paduden Express Forte may be associated with a slight increase in the risk of heart attack (myocardial infarction) or stroke. In connection with treatment with Paduden Express Forte, prolonged bleeding time, fluid retention (edema), high blood pressure, and heart failure have also been reported.
Based on the experience with the use of nonsteroidal anti-inflammatory drugs (NSAIDs), it is not possible to exclude cases of interstitial nephritis (kidney disease), nephrotic syndrome (a disorder characterized by the presence of protein in the urine and edema), or kidney failure. If any of the above symptoms occur, the patient should stop taking Paduden Express Forte and consult their doctor immediately.
If side effects occur, including any side effects not listed in this leaflet, the patient should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw;
tel: +48 22 492 13 01; fax: + 48 22 492 13 09;
website: https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, it is possible to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Store at a temperature below 30°C.
Do not use this medicine after the expiry date stated on the blister and carton after "EXP". The expiry date refers to the last day of the month.
Do not use this medicine if there are visible signs of capsule damage.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of unused medicines. This will help protect the environment.
The active substance of the medicine is ibuprofen. Each soft capsule contains 400 mg of ibuprofen.
The other ingredients are:
Core of the capsule: macrogol 600, potassium hydroxide, purified water
Shell of the capsule:gelatin, sorbitol liquid, partially dehydrated (E 420), and medium-chain triglycerides
Paduden Express Forte is a soft gelatin capsule, oval in shape (approximately 16 mm x 10 mm), colorless or slightly yellow, filled with a clear solution.
Paduden Express Forte is available in packs containing 10, 20, or 30 soft capsules in PVC/PVDC/Aluminum blisters in a cardboard box. Not all pack sizes may be marketed.
Ranbaxy (Poland) Sp. z o.o.
ul. Idzikowskiego 16
00-710 Warsaw
tel. 22 642 07 75
Laboratorios Liconsa S.A.
Pol. Ind. Miralcampo, Avenida Miralcampo nº7
19200, Azuqueca de Henares (Guadalajara)
Spain
Terapia S.A.
Strada Fabricii 124
400632 Cluj-Napoca, Cluj
Romania
Lithuania: Ibuprofen NVT 400 mg soft capsules
Latvia: Ibuprofen NVT 400 mg soft capsules
Estonia: Ibuprofen NVT
Romania: PADUDEN Express Forte 400 mg soft capsules
France: Ibuprofene Biogaran Conseil 400 mg, soft capsules
Poland: Paduden Express Forte
LT/H/0162/001-002/II/006/G and II/007
Date of last revision of the leaflet:29.05.2025
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.